Literature DB >> 30443884

Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.

Yunmei Dong1, Yuxin Chen1, Yan Tao1, Yilong Hao1, Lu Jiang1, Hongxia Dan1, Xin Zeng1, Qianming Chen1, Yu Zhou2.   

Abstract

A series of studies are dedicated to research the clinical outcomes of oral leukoplakia (OLK) treated with carbon dioxide laser (CO2 laser); however, the results vary from studies especially related to recurrence and malignant transformation. Hence, we performed this meta-analysis to precisely evaluate the malignant transformation of OLK dealt with CO2 laser and investigate the association between its malignant transformation and kinds of related risk factors, such as gender, clinical classification, long duration of leukoplakia, and degree of epithelial dysplasia and lesion regions. We performed a systematic search of the Cochrane Library, EMBASE, Pubmed, Web of Science, and SCOPUS. Single-arm rate of the overall risk of malignant transformation in OLK treated with CO2 laser was calculated using the Der-Simonian Liard method. We applied subgroup analysis to compare the risk of malignant transformation according to the degree of epithelial dysplasia, clinical type, and region of OLK. Moreover, a pooled odds ratio (OR) is calculated, along with its 95% confidence interval (CI), to compare the risk of malignant transformation according to patients' gender, tobacco, and alcohol consumption. We used the meta package of R software for quantitative data synthesis and analysis. The rate of malignant transformation of OLK treated with carbon dioxide laser ranged from 0 to 15.38% in included studies. The overall rate of malignant transformation of OLK treated with CO2 laser is 4.50% under the random effect model [95% CI 0.0305-0.0659]. A systematic review of observational studies of OLK reported that the estimated overall (mean) malignant transformation rate was 3.5%, with a wide range between 0.13 and 34.0%. Interestingly, our result revealed that it was the male, homogeneous type, no tobacco consumption, and without alcohol-use who had a higher tendency of malignancy after laser surgery. However, this result lack statistically significant data. Generally speaking, whether oral leukoplakia patients underwent laser surgical treatment or not, it may have little effect on malignant transformation. In addition, we strongly advise that it had better not to perform CO2 laser intervention on OLK patients with the following clinical characteristics: homogeneous type, male, no tobacco consumption, and without alcohol-use. Evidence is still lacking in terms of relationship between malignant transformation and risk factors among OLK patients managed with CO2 laser. Thus, these associations should be further investigated.

Entities:  

Keywords:  Carbon dioxide laser; Malignant transformation; Meta-analysis; Oral dysplasia; Oral leukoplakia; Oral potentially malignant disorders

Mesh:

Year:  2018        PMID: 30443884     DOI: 10.1007/s10103-018-2674-7

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  3 in total

1.  Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Han Yang; Cheng-Ming Luo; Pei-Wen Wu
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

2.  Clincopathological characteristics and treatment outcomes of oral leukoplakia by carbon dioxide laser excision in the elderly patients.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Cheng Hwang; Tai-An Chen
Journal:  Head Neck       Date:  2020-01-13       Impact factor: 3.147

3.  Histological Effects of an Innovative 445 Nm Blue Laser During Oral Soft Tissue Biopsy.

Authors:  Gaspare Palaia; Daniele Pergolini; Leonardo D'Alessandro; Raffaella Carletti; Alessandro Del Vecchio; Gianluca Tenore; Cira Rosaria Tiziana Di Gioia; Umberto Romeo
Journal:  Int J Environ Res Public Health       Date:  2020-04-13       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.